TJ 54
Latest Information Update: 28 Jul 1999
At a glance
- Originator Kansai Medical University; Tsumura
- Developer Kansai Medical University
- Class Antidementias; Herbal medicines; Neuroprotectants
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Dementia
Most Recent Events
- 28 Jul 1999 No-Development-Reported for Dementia in Japan (PO)
- 22 Jan 1997 Phase-II clinical trials for Dementia in Japan (PO)